Torrent Pharma To Acquire Controlling Stake In JB Chemicals From KKR For Rs 25,689 Crore
Torrent Pharmaceuticals will acquire a controlling stake in JB Chemicals and Pharmaceuticals Ltd. from global investment firm KKR in a deal valued at Rs 25,689 crore on a fully diluted basis, the companies said on Sunday. The transaction includes an acquisition of a majority stake followed by a full merger of the two companies.
Torrent has signed definitive agreements to acquire 46.39% equity in JB Pharma at a price of Rs 1,600 per share in the first phase, translating to a transaction value of Rs 11,917 crore, according to a statement to the exchanges. The deal will then trigger a mandatory open offer for an additional 26% stake at a price of Rs 1,639.18 per share, the statement said.
Torrent has also said that it intends to acquire up to 2.80% of equity from certain JB Pharma employees at the same price as KKR, the statement added.
Following the stake acquisition, Torrent will merge JB Pharma into its operations through a scheme of arrangement, the statement said, adding that JB Pharma shareholders holding 100 shares will receive 51 shares of Torrent after the merger.
Deal Rationale
Torrent said the transaction strengthens its domestic market position while expanding its global footprint. "JB Pharma brings a growing India portfolio and access to international markets, including Russia and South Africa. The acquisition also provides entry into the CDMO (contract development and manufacturing organisation) segment, which Torrent expects to be a long-term growth area," the statement said.
The company further said the merger would enable operational integration across functions, improve scale, and support platform diversification. JB Pharma's presence in chronic therapies and its branded product base complement Torrent's existing portfolio and align with its strategy to grow in both India and select international markets.
Approvals and Advisors
The deal is subject to approvals from the Securities and Exchange Board of India, stock exchanges, the Competition Commission of India, and the National Company Law Tribunal as per the procedure.
Moelis & Company and NovaOne acted as financial advisors to Torrent, while Khaitan & Co. served as legal counsel. Ernst and Young Merchant Banking Services and BDO Valuation Advisory acted as registered valuers. KKR was advised by Kotak Investment Banking, Rothschild & Co. Goldman Sachs (India) Securities Pvt. Ltd. acted as the financial advisor to JB Pharma. Legal counsel to KKR and JB Pharma were Shardul Amarchand Mangaldas & Co. and AZB & Partners, respectively.
-
We May Need Another Tukaram Mundhe To Fight Air Pollution | The Reason Why
Developers may install basic measures such as sprinklers and green nets, resume work, and continue violating rules when this equipment stops working.
-
Extracting Value From Battery Scrap Could Be Challenging For India | The Reason Why
A discarded lithium-ion battery still contains valuable materials such as lithium, nickel and cobalt. These can be recovered and reused. When such batteries are crushed and shredded, they produce a dark powder called black mass.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.